TRDA
Entrada Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Entrada Therapeutics (TRDA) Stock: Buy, Sell, or Hold?
$5.31
-0.13 (-2.39%)
âŧ
5d:
+16.7%
30d:
+16.7%
90d:
-28.82%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
33/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$4.54 â $5.34
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-1.6x
Next 12M consensus est.
Wall Street Target
$18.75
+244.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.26 / $5.49
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: TRDA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When TRDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TRDA is currently trading at $5.31, which is considered slightly high relative to its 30-day fair value range of $4.54 to $5.34.
Technical Outlook: Technically, TRDA is in a strong downtrend. Immediate support is located at $4.25, while resistance sits at $5.49.
Market Sentiment: TRDA scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.75 (+244.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TRDA is in a strong downtrend. Immediate support is located at $4.25, while resistance sits at $5.49.
Market Sentiment: TRDA scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $18.75 (+244.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$4.54 -
$5.34
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$4.54 -
$5.34
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$4.26
Resistance Level
$5.49
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 244.7% below Wall St target ($18.75)
- WARNING: Composite score 33/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.62
Wall Street Target
$18.75
(+244.7%)
Revenue Growth (YoY)
-43.9%
Share TRDA Analysis
Share this live TRDA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TRDA)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
A single bullish message on StockTwits expresses optimism towards $TRDA.
Key Retail Themes:
Positive sentiments
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:23 PM ET
Data refreshes hourly during market hours. Next update: 3:23 PM
Data refreshes hourly during market hours. Next update: 3:23 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TRDA Research Pages